Ozempic Was Made for Diabetes and Weight Loss. But It May…

Ozempic Was Made for Diabetes and Weight Loss. But It May Also Be Treating Depression. Published: May 6, 2026 | Category: Mental Health, Endocrinology, Pharmacology | Medically reviewed by TALMedora Health Desk Semaglutide, the drug behind Ozempic and Wegovy, became famous for weight loss. Celebrities endorsed it. Social media exploded with transformation stories. Demand outpaced supply. But a new study published May 4, 2026, suggests this drug may be doing something no one expected: improving mental health. Researchers tracking nearly 100,000 people found that GLP-1 drugs like semaglutide are associated with significantly lower rates of depression and anxiety compared to people not taking them. This was not a small effect. And it was not a coincidence. The study analyzed health records of nearly 100,000 people taking GLP-1 drugs for diabetes or weight loss over several years. Researchers compared their mental health outcomes to people with similar health profiles who were not taking these medications. The results were striking: people on semaglutide reported lower rates of depression and anxiety than the control group. The mental health benefits appeared independent of weight loss, meaning people felt better emotionally even before they lost significant weight. The mechanism is not yet fully understood, but researchers believe GLP-1 drugs may directly affect brain chemistry, inflammation, and reward pathways in ways that improve mood and reduce anxiet